Literature DB >> 11897128

Expression site activation in Trypanosoma brucei with three marked variant surface glycoprotein gene expression sites.

Sebastian Ulbert1, Inês Chaves, Piet Borst.   

Abstract

The genes for the Variant Surface Glycoprotein (VSG) of Trypanosoma brucei are transcribed in telomeric expression sites (ESs). There are about 20 different ESs per trypanosome nucleus. Usually, only one is active at a time, but trypanosomes can switch the ES that is active at a low rate (<10(-5) per cell per generation). To study activation and silencing of ESs, we have generated a line of T. brucei 427 with three ESs marked with a different drug resistance gene. We show that a selection with any combination of two of these drugs leads to an unstable double-resistant phenotype in which the two ESs containing the corresponding marker genes switch backward and forward at a very high rate (>10(-1) per cell per generation). Unstable triple-resistant trypanosomes were not obtained. We conclude that the unstable rapid-switching state is a natural intermediate in ES switching. It only involves two ESs, whereas the other ESs are not expressed. Furthermore, we show that "inactive" ESs can exist at several different stable levels of activation. Whereas, a "silent" ES shows a low level of expression of promoter proximal sequences, the level of activation can be reversibly increased, leading to partially activated ESs.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11897128     DOI: 10.1016/s0166-6851(02)00003-8

Source DB:  PubMed          Journal:  Mol Biochem Parasitol        ISSN: 0166-6851            Impact factor:   1.759


  9 in total

1.  VSG switching in Trypanosoma brucei: antigenic variation analysed using RNAi in the absence of immune selection.

Authors:  Niall Aitcheson; Suzanne Talbot; Jesse Shapiro; Katie Hughes; Carl Adkin; Thomas Butt; Karen Sheader; Gloria Rudenko
Journal:  Mol Microbiol       Date:  2005-09       Impact factor: 3.501

Review 2.  Cell biology of the trypanosome genome.

Authors:  Jan-Peter Daniels; Keith Gull; Bill Wickstead
Journal:  Microbiol Mol Biol Rev       Date:  2010-12       Impact factor: 11.056

3.  Expression of the human DNA glycosylase hSMUG1 in Trypanosoma brucei causes DNA damage and interferes with J biosynthesis.

Authors:  Sebastian Ulbert; Mike Cross; Robert J Boorstein; George W Teebor; Piet Borst
Journal:  Nucleic Acids Res       Date:  2002-09-15       Impact factor: 16.971

4.  Phleomycin increases transformation efficiency and promotes single integrations in Schizophyllum commune.

Authors:  Arend F van Peer; Charissa de Bekker; Arman Vinck; Han A B Wösten; Luis G Lugones
Journal:  Appl Environ Microbiol       Date:  2008-12-29       Impact factor: 4.792

5.  Interactions among Trypanosoma brucei RAD51 paralogues in DNA repair and antigenic variation.

Authors:  Rachel Dobson; Christopher Stockdale; Craig Lapsley; Jonathan Wilkes; Richard McCulloch
Journal:  Mol Microbiol       Date:  2011-05-26       Impact factor: 3.501

6.  Distinct roles for two RAD51-related genes in Trypanosoma brucei antigenic variation.

Authors:  Chris Proudfoot; Richard McCulloch
Journal:  Nucleic Acids Res       Date:  2005-12-02       Impact factor: 16.971

7.  Dynamic colocalization of 2 simultaneously active VSG expression sites within a single expression-site body in Trypanosoma brucei.

Authors:  James Budzak; Louise E Kerry; Aris Aristodemou; Belinda S Hall; Kathrin Witmer; Manish Kushwaha; Carys Davies; Megan L Povelones; Jacquelyn R McDonald; Aakash Sur; Peter J Myler; Gloria Rudenko
Journal:  Proc Natl Acad Sci U S A       Date:  2019-07-29       Impact factor: 11.205

8.  Transcription Dependent Loss of an Ectopically Expressed Variant Surface Glycoprotein during Antigenic Variation in Trypanosoma brucei.

Authors:  Emilia Jane McLaughlin; Karinna Rubio-Pena; Annick Dujeancourt-Henry; Lucy Glover
Journal:  mBio       Date:  2022-03-01       Impact factor: 7.786

Review 9.  Antigenic variation in Trypanosoma brucei: joining the DOTs.

Authors:  Chris Stockdale; Michal R Swiderski; J David Barry; Richard McCulloch
Journal:  PLoS Biol       Date:  2008-07-29       Impact factor: 8.029

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.